These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33500777)

  • 1. Option-based guarantees to accelerate urgent, high-risk vaccines: a new market-shaping approach.
    Manheim D; Foster D
    F1000Res; 2020; 9():1154. PubMed ID: 33500777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine supply, demand, and policy: a primer.
    Muzumdar JM; Cline RR
    J Am Pharm Assoc (2003); 2009; 49(4):e87-99. PubMed ID: 19589753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
    Forman R; Anderson M; Jit M; Mossialos E
    Vaccine; 2020 Sep; 38(39):6075-6077. PubMed ID: 32773244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there light at the end of the Covid-19 tunnel?
    Mortimer PP
    Rev Med Virol; 2021 May; 31(3):e2173. PubMed ID: 33002254
    [No Abstract]   [Full Text] [Related]  

  • 5. Advantages of single-use technology for vaccine fill-finish operations.
    Jenness E; Walker S
    PDA J Pharm Sci Technol; 2014; 68(4):381-3. PubMed ID: 25035260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness.
    Berndt ER; Glennerster R; Kremer MR; Lee J; Levine R; Weizsäcker G; Williams H
    Health Econ; 2007 May; 16(5):491-511. PubMed ID: 17013993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic.
    Neumann PJ; Cohen JT; Kim DD; Ollendorf DA
    Health Aff (Millwood); 2021 Jan; 40(1):53-61. PubMed ID: 33211534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of coronavirus vaccines and their pricing.
    Light DW; Lexchin J
    J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097
    [No Abstract]   [Full Text] [Related]  

  • 11. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing fractional doses of COVID-19 vaccines.
    Więcek W; Ahuja A; Chaudhuri E; Kremer M; Simoes Gomes A; Snyder CM; Tabarrok A; Tan BJ
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Advance Purchasing Commitments in Government Drug Price Negotiations: Lessons From the COVID-19 Response.
    Socal MP; Anderson GF
    Am J Public Health; 2021 Apr; 111(4):652-657. PubMed ID: 33507827
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerating vaccine development and deployment: report of a Royal Society satellite meeting.
    Bregu M; Draper SJ; Hill AV; Greenwood BM
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2841-9. PubMed ID: 21893549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?
    Towse A; Chalkidou K; Firth I; Kettler H; Silverman R
    Value Health; 2021 May; 24(5):625-631. PubMed ID: 33933230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
    McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418
    [No Abstract]   [Full Text] [Related]  

  • 20. Covid-19: an economic perspective on vaccinating the world.
    Donaldson C; Biosca O
    BMJ; 2021 Jun; 373():n1498. PubMed ID: 34130993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.